```json
{
"content": [
{
"type": "paragraph",
"content": "The insomnia therapy market encompasses therapeutic solutions for chronic sleep disorders, including pharmaceuticals, cognitive behavioral therapy (CBT), and digital health tools. As sleep disorders affect over 30% of adults globally, the insomnia therapy market size is a critical metric for stakeholders in healthcare innovation. This market is defined by its intersection of clinical, technological, and behavioral interventions, with a focus on addressing both acute and chronic insomnia."
},
{
"type": "paragraph",
"content": "Estimated at $3.2 billion in 2025, the insomnia therapy market is projected to grow at a compound annual growth rate (CAGR) of 6.8% from 2026 to 2033, reaching $6.1 billion by 2033. Key macro drivers include the rise in sleep disorders linked to stress, aging populations, and digital health adoption. Industry expansion is further fueled by regulatory support for CBT-I therapies and the emergence of AI-driven sleep coaching apps. North America remains the largest region due to high healthcare spending, while the Asia-Pacific market is the fastest-growing, driven by urbanization and rising awareness of sleep health. Strategic partnerships between pharma firms and digital health platforms will be pivotal in shaping the market forecast."
},
{
"type": "chart",
"chartType": "segment-stacked",
"data": {
"segments": ["Non-Pharmacological", "Pharmacological", "Digital Therapeutics"],
"periods": ["2021", "2022", "2023", "2024", "2025", "2026", "2027", "2028", "2029", "2030", "2031", "2032", "2033"],
"values": [
[800, 850, 920, 1000, 1100, 1220, 1350, 1490, 1640, 1800, 1970, 2150, 2340], // Non-Pharmacological
[1800, 1850, 1900, 1950, 2000, 2050, 2100, 2150, 2200, 2250, 2300, 2350, 2400], // Pharmacological
[300, 350, 400, 470, 550, 650, 780, 920, 1080, 1250, 1440, 1650, 1880] // Digital Therapeutics
]
}
},
{
"type": "paragraph",
"content": "The segment-stacked chart above illustrates the insomnia therapy marketโs structural evolution from 2021 to 2033. Non-pharmacological therapies (e.g., CBT-I) dominate in 2025 but trail digital therapeutics, which are surging due to wearable integration and telemedicine adoption. Pharmacological solutions remain stable, reflecting regulatory scrutiny and patent expirations. Strategic investments in AI-based sleep diagnostics and personalized treatment algorithms are reshaping the growth outlook, with digital therapeutics poised to overtake pharmacological therapies by 2033."
}
]
}
```
